Emerald Clinical

Emerald Clinical Emerald Clinical is a global full-service CRO with 25+ years’ experience.

We deliver Phase I–IV & real-world studies worldwide, partnering with biotech & top pharma to advance therapies in Renal, Oncology, Autoimmune & more. With over 20 years of experience and more than 500 people managing 38 geographical locations throughout the Asia-Pacific region, USA, and Europe, George Clinical provides the full range of clinical trial services to biopharmaceutical, medical device, and diagnostic customers, for all trial phases, registration and post-marketing trials.

15/06/2026

Did you miss our webinar, 'Improve Oncology Clinical Trial Readiness for Faster Proof-of-Concept,' presented by Luke Gill, Vice President and Global Head of Oncology and Medical Affairs, and Yong Wang, Head of Biometrics?

Its now available on demand – https://bit.ly/3S4oSdS

• Bayesian Designs: Replaces rigid 3+3 rules with flexible models (like BOIN) to find optimal benefit-risk doses instead of just maximum tolerated doses.

• Master Protocols: Uses basket, umbrella, and platform structures to run multiple biomarker-driven sub-studies under one overarching infrastructure.

• Real-World Evidence (RWE): Employs external control arms and hybrid models to supplement trial data for rare diseases and fast-track approvals.

• Global Regulatory Agility: Accelerates early ex*****on in Australia, builds FDA credibility, and integrates China into early Phase I/II proof-of-concept.

Regulatory Agility

Emerald Clinical is excited to announce that Maha Rinaudo is heading to the BIO International Convention in San Diego Ju...
13/06/2026

Emerald Clinical is excited to announce that Maha Rinaudo is heading to the BIO International Convention in San Diego June 22-25, 2026!

Are you looking to explore new trial efficiencies, discuss upcoming protocols, or simply expand your network — Emerald Clinical pairs deep global reach with localized scientific precision to accelerate pipeline timelines.

Secure your meeting with Maha today or drop a comment below to coordinate a time to connect. https://bit.ly/4r8ELvG

See you there!

Wishing our Philippines team a joyful and reflective celebration — thank you for all you do.
12/06/2026

Wishing our Philippines team a joyful and reflective celebration — thank you for all you do.

Why do you need Emerald Clinical’s Renal Clinical Development Advisory Board?Emerald Clinical’s Renal Clinical Developme...
11/06/2026

Why do you need Emerald Clinical’s Renal Clinical Development Advisory Board?

Emerald Clinical’s Renal Clinical Development Advisory Board helps you:
• Identify and mitigate key risks early
• Define the right patient population, endpoints, and dosing
• Build a data package aligned with regulatory approval and patient access

By combining regulatory insight with real-world clinical expertise, we ensure your therapy is positioned for success—not just approval, but adoption.

Find out how we help you deliver therapies that address real unmet needs and elevate the standard of care. https://bit.ly/4qSuUuo

10/06/2026

Groundbreaking first: Emerald Clinical delivered China’s inaugural oncology immunonutrition (FSMP) trial—navigating evolving regulations, complex logistics, and cross‑departmental coordination to enroll 300+ patients, meet timelines, and produce regulatory‑quality data.

Read how our China expertise, operational flexibility, and hands‑on partnership made this novel trial possible: https://bit.ly/3Qrd9oA

Sydney, we are on the road! ✈️ Our Australia team is thrilled to be part of ARCS 2026 (on June 11–12). You’re welcome to...
09/06/2026

Sydney, we are on the road! ✈️

Our Australia team is thrilled to be part of ARCS 2026 (on June 11–12). You’re welcome to have the conversation on how to drive faster recruitment, deeper patient engagement, and meaningful results that move medicine forward with us.

We are pleased to have Alina Yoffe ([email protected]) on Day 2 (June 11) and Jacqueline Jenkins ([email protected]) on Day 3 (June 12).

Please feel free to contact by email to book an appointment to discuss this further!

Let’s talk about driving the industry forward. See you there! 🚀

Learn more about Emerald Clinical here - http://www.emeraldclinical.com

08/06/2026

Rescued Phase II AML study — full‑service turnaround.

Called in to salvage a small Phase II AML trial plagued by a non‑cooperative CRO, activation delays, low recruitment and sponsor turnover, we implemented an independent transition plan, weekly start‑up tracking, streamlined budgets, and focused site engagement (sponsor‑attended initiations, PI calls, targeted training).

Result: smooth Phase I→II transition, restored timelines and budgets, improved enrollment and investigator morale.

Read the case study: https://bit.ly/4dL51c1

Already in clinical trials?It’s not too late to de-risk your renal program.Emerald Clinical’s Renal Clinical Development...
07/06/2026

Already in clinical trials?

It’s not too late to de-risk your renal program.

Emerald Clinical’s Renal Clinical Development Advisory Board can support your program at any stage—from early development through Phase III and beyond.
While early engagement is ideal, their expertise becomes even more valuable as complexity increases.

✔️ Reposition your program for the next development phase
✔️ Navigate stricter regulatory expectations
✔️ Optimize for payer engagement and patient access

As studies move into late-stage development, operational demands intensify. That’s where real-world expertise matters most—combining strategic insight with “boots-on-the-ground” delivery to guide critical decisions.

Because in renal, it’s not just about progress—it’s about staying on the right path at every stage.
https://bit.ly/4qSuUuo

Ensure your trial designs keep pace with your science.🧬The shift toward adaptive, data-driven oncology trials isn't just...
05/06/2026

Ensure your trial designs keep pace with your science.🧬

The shift toward adaptive, data-driven oncology trials isn't just a trend—it’s a necessity for technical success. At Emerald Clinicals, we believe the path to faster Proof-of-Concept (PoC) lies at the intersection of advanced mathematics and global integration.

Join Luke Gill (VP, Global Head of Oncology) and Dr. Yong Wang (Head of Biometrics) for a technical deep-dive on June 11th.

Register here now! https://bit.ly/4wFvS0j

🗓️ Thursday, June 11, 2026
🕙 10:00 AM – 11:00 AM EDT

In this session, we explore:
🔹 Beyond Dose Escalation: How Bayesian designs (like BOIN) identify the optimal biological dose with fewer patients and higher confidence.
🔹 The Power of Master Protocols: How basket and umbrella trials serve as a framework for synchronized PoC ex*****on across the US, Europe, and China.
🔹 Strategic RWE: Utilizing high-quality registry and EHR data from China to strengthen regulatory and payer discussions.

Don't let rigid trial designs slow down your innovation. Learn how to compress timelines and increase the probability of success.

📅 Save your seat here: 🔗 https://bit.ly/4wFvS0j

Address

#32-01 300 Beach Road, The Concourse
Singapore
199555

Website

Alerts

Be the first to know and let us send you an email when Emerald Clinical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category